Symbiotec Pharmalab Limited (NSE:SYMBIOTEC)

India · Delayed Price · Currency is INR

1,197.50

-10.90 (-0.90%)

Last updated: Oct 22, 2026, 3:29 PM IST

Market Cap	76.95B
Revenue (ttm)	8.84B +23.4%
Net Income	940.20M -6.1%
EPS	14.98 -16.7%
Shares Out	64.26M
PE Ratio	79.91
Forward PE	54.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	311,689
Open	1,194.10
Previous Close	1,208.40
Day's Range	1,169.60 - 1,217.90
52-Week Range	934.20 - 1,309.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 22, 2026

About Symbiotec Pharmalab

Symbiotec Pharmalab Limited develops, manufactures, and markets active pharmaceutical ingredients (APIs) in India. The company provides cortico-steroid and hormone (Steroid) APIs; nutraceuticals; and other services. The company was founded in 1995 and is based in Indore, India. [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 1995

Employees 1,915

Stock Exchange National Stock Exchange of India

Ticker Symbol SYMBIOTEC

Full Company Profile

Financial Performance

In fiscal year 2026, Symbiotec Pharmalab's revenue was 8.69 billion, an increase of 15.65% compared to the previous year's 7.52 billion. Earnings were 1.10 billion, an increase of 13.53%.

Financial Statements